Ocariza, Kakashca Faye L.
HRN: 24-37-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/07/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/07/2024
01/14/2024
IV
800mg
Q6hours
PCAP Severe; Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes